1 中华医学会肝病学分会脂肪肝和酒精性肝病学组, 中国医师协会脂肪性肝病专家委员会. 酒精性肝病防治指南(2018更新版)[J].中华肝脏病杂志, 2018, 26(3): 188-194.
2Ding L, Oligschlaeger Y, Shiri-Sverdlov R, et al. Nonalcoholic fatty liver disease[J]. Handb Exp Pharmacol, 2022, 270: 233-269.
3 中国肺癌早诊早治专家组, 中国西部肺癌研究协作中心. 中国肺癌低剂量CT筛查指南(2023年版)[J]. 中国肺癌杂志, 2023, 26(1): 1-9.
4 李蒙, 张丽, 张泽伟, 等. 胸部低剂量CT肺癌筛查在检出其他常见慢性非传染性疾病的价值[J]. 中华放射学杂志, 2022, 56(2):217-220.
5 娄莹, 马文君, 王子君, 等. 中国高血压临床实践指南计划书[J].中华心血管病杂志, 2022, 50(7): 671-675.
6 中华中医药学会糖尿病基层防治专家指导委员会. 国家糖尿病基层中医防治管理指南(2022)[J]. 中华糖尿病杂志, 2023, 15(2):100-117.
7Stewart J, McCallin T, Martinez J, et al. Hyperlipidemia[J]. Pediatr Rev, 2020, 41(8): 393-402.
8 李艳, 任俊红. 超声诊断颈动脉粥样硬化斑块的方法和规范化应用[J]. 中华全科医师杂志, 2022, 21(2): 105-108.
9 中国民族卫生协会重症代谢疾病分会, 高尿酸血症相关疾病诊疗多学科共识专家组. 中国高尿酸血症相关疾病诊疗多学科专家共识(2023年版)[J]. 中国实用内科杂志, 2023, 43(6): 461-480.
10 Saiman Y, Duarte-Rojo A, Rinella ME. Fatty liver disease: Diagnosis and stratification[J]. Annu Rev Med, 2022, 73: 529-544.
11 Goldshtein I, Chodick G, Kochba I, et al. Identification and characterization of nonalcoholic fatty liver disease[J]. Clin Gastroenterol Hepatol, 2020, 18(8): 1887-1889.
12 Erard D, Villeret F, Chouik Y, et al. Dual alcohol and metabolic-related liver disease: Results from a population of liver transplant patients[J]. Liver Int, 2024, 44(2): 422-432.
13 仇燕, 钱波, 仲怀琴. BMI正常人群幽门螺杆菌感染与非酒精性脂肪性肝病的相关性分析[J]. 国际消化病杂志, 2023, 43(3): 154-158, 164.
14 Jeon S, Carr R. Alcohol effects on hepatic lipid metabolism[J]. J Lipid Res, 2020, 61(4): 470-479.
15 Chen B, Sun L, Zeng G, et al. Gut bacteria alleviate smoking-related NASH by degrading gut nicotine[J]. Nature, 2022, 610(7932): 562-568.
16 Pirola CJ, Sookoian S. Non-alcoholic fatty liver disease mediates the effect of obesity on arterial hypertension[J]. Liver Int, 2023, 43(10):2167-2176.
17 Lee CH, Lui DT, Lam KS. Non-alcoholic fatty liver disease and type 2 diabetes: An update[J]. J Diabetes Investig, 2022, 13(6): 930-940.
18 陈兆斌, 黄丽媛, 王炳元, 等. 代谢相关脂肪性肝病与2型糖尿病的关系及共病机制研究进展[J]. 临床肝胆病杂志, 2023, 39(10):2454-2459.
19 Man S, Deng Y, Ma Y, et al. Prevalence of liver steatosis and fibrosis in the general population and various high-risk populations: A nationwide study with 5.7 million adults in China[J]. Gastroenterology, 2023, 165(4): 1025-1040.
20 侯淑惠, 邓晓玲, 次白, 等. 尿酸参与代谢相关性脂肪性肝病发生、发展的分子机制研究进展[J]. 肝脏, 2023, 28(8): 990-994.
21 Li Y, Chen C, Lu L, et al. Cadmium exposure in young adulthood is associated with risk of nonalcoholic fatty liver disease in midlife[J]. Dig Dis Sci, 2022, 67(2): 689-696.
22 Balakrishnan M, Rehm J. A public health perspective on mitigating the global burden of chronic liver disease[J]. Hepatology, 2024, 79(2): 451-459.